• About us
• Contact

Advertisement

Organisation › Details

Oncgnostics GmbH

Founded as a spin-off from the University Womens' Hospital Jena, oncgnostics focuses on in vitro diagnostic tests for the early and accurate detection of cancer utilizing proprietary epigenetic biomarkers. The diagnostic products will allow earlier detection of more cancer cases and thus contribute to the improvement of therapeutic success. The initial product developed, GynTect®, allows for the rapid and reliable detection of cervical precancerous lesions and cancer. Through strategic alliances with other industry leaders, oncgnostics aims to extend its reach around the world. *

 

	Start	2012-02-01 splitoff
	Predecessor	University of Jena (Friedrich-Schiller-Universität Jena)
	Industry	molecular diagnostics
	Industry 2	GynTect® test
	Person	Hansel, Alfred (Oncgnostics GmbH 201204 Managing Director + Co-founder)
	Person 2	Schmitz, Martina (Oncgnostics GmbH 201204 Managing Director + Co-founder)
	Region	Jena
	Country	Germany
	Street	41 Löbstedter Str.
	City	07749 Jena
	Tel	+49-3641-508456
		Address record changed: 2022-09-18
Basic data	Employees	A: 1 to 10 (2017-09-07)
		* Document for »About Section«:
		Record changed: 2023-12-30

Advertisement

More documents for Oncgnostics GmbH

• [1] Oncgnostics GmbH. (9/5/23). "Press Release: Hong Kong Firm Invests in Jena-based Oncgnostics GmbH". Jena....
• [2] Oncgnostics GmbH. (8/25/22). "Press Release: German Oncgnostics GmbH‘s Innovation in the Area of Cervical Cancer Diagnostics Now also Available in China". Jena....
• [3] Oncgnostics GmbH. (10/17/18). "Press Release: Cervical Cancer Screening. Oncgnostics Closes further Investment Round". Jena....
• [4] Oncgnostics GmbH. (10/2/18). "Press Release: Oncgnostics GmbH Retains Biotech Alliances International Inc. to Support Global Partnering and Distribution Strategy". San Francisco, CA & Jena....
• [5] Oncgnostics GmbH. (4/16/18). "Press Release: Test for Uterine Cancer in Portugal. Biotech Firm Oncgnostics Grants Exclusive Licence for Cancer Screening Test". Lisbon & Jena....
• [6] Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena....
• [7] Oncgnostics GmbH. (4/5/17). "Press Release: GynTect Soon Available in China. Oncgnostics Grants Exclusive License for GynTect to the Chinese Sinopharm Subsidiary CJMT – Approval for the Chinese Market Planned". Jena....
• [8] Oncgnostics GmbH. (2/20/17). "Pressemitteilung: Erfolgreich finanziert – BioTech-Unternehmen oncgnostics erhält eine Million Euro nach Crowdfunding-Kampagne". Jena....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.